Last year in January, the FDA inspectors found bacteria at the plant after receiving complaints. Abbott makes Similac, the country's top-seller baby formula. Markets are messy—but the right setups can ...

Abbott Laboratories (NYSE: ABT) has generally been a good investment to hold over the years. Its business is diverse. And the company not only pays a dividend but also has a terrific track record of ...

Despite the flood of apocalyptic warnings from COVID-19 testmakers who kicked off 2022 with stark predictions of dwindling diagnostic sales and, therefore, major hits to their year-over-year results, ...

PHILADELPHIA -- Abbott Nutrition is recalling one lot of Similac PM 60/40 powdered infant formula due to another report of a dangerous bacterial infection. The Centers for Disease Control and ...

Abbott Laboratories is coming off a lackluster 2022, when sales showed minimal growth. Multiple headwinds negated the diversified business that usually makes Abbott a safe buy. Loosening COVID-19 ...